Antibodies/Other Flashcards

1
Q

Pembrolizumab class

A

human mab to PD-1 and block PD-L1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Atezolizumab class

A

human mab to PD-L1 and block PD-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ipilimumab target

A

human mab to CTLA-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

trastuzumab pertuzimab

A

humanized mab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cetuximab

A

chimeric mab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

bevacizumab

A

humanized mab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

rituximab

A

CD20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

daratumumab

A

CD38

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

olaparib

A

PARP inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Palbociclib

A

CDK4/6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

bortemzomib

A

inhibits proteasomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

venetoclax

A

BCL-2 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pomalidomide

A

degrades IKZF-TF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

trastuzumab emtansine

A

ADC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

trastuzumab deruxtecan

A

ADC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

blinatumomab

A

BiTE to CD3

16
Q

mosunetuzumab

A

BiTE to CD3 and CD20

17
Q

teclistamab

A

BiTE to CD3 on T cells

18
Q

taquetamab

A

BiTE to CD3 on T cells

19
Q

Sipuleucel-T

A

PAP-GM-CSF